Canonical product evidence map
BPC-157 Evidence Map
A source-linked map that keeps animal, cell, review and FDA compounding records separate for BPC-157.
- 33
- unique source records
- 7
- research types
- 2008–2026
- source-year range
Evidence distribution
See the source mix before reading the conclusions.
A large record count does not imply mature human evidence. The model and source type determine which question a record can answer.
Research type
Study model
Source-linked records
33 records connected to BPC-157
Records are deduplicated by canonical source URL and keep their model, type and evidence-tier labels visible.
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats
Biçer O, et al. Jt Dis Relat Surg. 2026;37:822–837. PMID 42542926.
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Evidence review. 2026. PMID 41476424.
Bachem: peptide notation and terminal modifications
Bachem: peptide notation and terminal modifications. Accessed 2026-10-03.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
Agilent: Five Tips for Chromatographic Integration
Agilent: Five Tips for Chromatographic Integration. Accessed 2026-10-05.
Thermo Fisher: handling and storage instructions for standard peptides
Thermo Fisher: handling and storage instructions for standard peptides. Accessed 2026-10-03.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine
Systematic review. 2025. PMID 40756949.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Literature and patent review. 2025. PMID 40005999.
ICH Q2(R2): Validation of Analytical Procedures
International Council for Harmonisation. Step 4, adopted November 2023; error-corrected 2025.
Primary publication — PubMed 25415472
Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-19077. doi:10.3390/molecules191119066. PMID:25415472.
N-terminal acetylated thymosin beta 4 fragment identified in TB-500
Analytical study. 2012. PMID 22962027.
Primary publication — PubMed 18061177
Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178. PMID 18061177.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
Care and handling of peptides
Care and handling of peptides
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
ICH Q2(R2): Validation of Analytical Procedures
Defines validation characteristics and distinguishes quantitative analytical purposes.
Cell components: amino acids and peptide bonds
Cell components: amino acids and peptide bonds
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37
Research news reference — pubmed.ncbi.nlm.nih.gov — news-20
ICH Q2(R2) Validation of Analytical Procedures
ICH Q2(R2) Validation of Analytical Procedures
The International System of Units (SI), 9th edition
The International System of Units (SI), 9th edition
Pyrogen and Endotoxins Testing: Questions and Answers
Pyrogen and Endotoxins Testing: Questions and Answers
Teaching reference — database.ich.org — ICH_Q2(R2)_Guideline_2023_1130_ErrorCorrection_2025.pdf
Teaching reference — www.thermofisher.com — overview-mass-spectrometry.html
Influence and Control of Column Temperature in Successful Peptide Mapping
Influence and Control of Column Temperature in Successful Peptide Mapping
Thermo Fisher: TN50 amino acid analysis
Public reference, not NHD batch evidence.
Published BPC-157 sequence record
Public reference, not NHD batch evidence.
ICH Q2(R2): Validation of Analytical Procedures
Official analytical-validation framework; not evidence that a specific catalog lot has been tested.
ICH Q14: Analytical Procedure Development
Official analytical-development framework; included as general method guidance only.
BPC-157 Achilles tendon study in rats and cultured tendocytes
Earlier component-specific preclinical context; PMID 14554208.
Evidence boundary
A source set is not a clinical recommendation.
- Human, animal, in-vitro, analytical, registry and regulatory records remain separate evidence categories.
- A published intervention or approved finished medicine does not verify the identity or quality of a catalog research lot.
- Record inclusion does not mean every finding has been independently replicated or applies outside its stated population and model.
Continue researching
